您的位置: 首页 > 农业专利 > 详情页

Système d'anticoagulation de citrate souple pendant un traitement sanguin extracorporel utilisant la précompensation
专利权人:
B. Braun Avitum AG
发明人:
申请号:
EP14191205.5
公开号:
EP3015124B1
申请日:
2014.10.31
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
System (1) for extracorporeal blood treatment, with:a haemofiltration device (2),means (3) for pumping blood through the haemofiltration device (2),citrate addition means (4) arranged upstream of the haemofiltration device (2) in the direction of blood flow configured to add citrate to the blood,calcium addition means (5) arranged downstream of the haemofiltration device (2) in the direction of blood flow configured to add calcium to the blood, and control means (6) configured to activate or inactivate the citrate addition means (4) and/or the calcium addition means (5), wherein the control means (6) is adapted to activate the citrate addition means (4) at or before the beginning of blood treatment, to determine the elapse of a first time period (t1) after the blood treatment is actavitated and to continue to operate the citrate addition means (4) until the end of blood treatment, at which point in time the citrate addition means (4) is inactivated, wherein the control means (6) is further adapted to activate the calcium addition means (5) after the first time period has elapsed, when total extracopropreal blood volume in the system has been filtered and citrate treated, to continue to operate the calcium addition means (5) in an active state during blood treatment and to continue to operate the calcium addition means (5) in an active state after the end of blood treatment, until a second time period (t2) has elapsed after the end of treatment.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充